Avak Kahvejian

Avak Kahvejian, a renowned inventor and entrepreneur with a passion for biology, technology, and design, has made significant contributions to the fields of biotechnology and biochemistry. He holds a Ph.D. and a B.Sc. in Biochemistry from McGill University and has studied General Sciences at Marianopolis College. Kahvejian's journey started at PerSeptive BioSystems as a Product Evaluation Lab Associate before holding various roles at Helicos BioSciences, including Director of Business Development, Product Manager, and Vice President of Business Development. He has also served as a Partner and currently as a General Partner at Flagship Pioneering, a renowned innovator of life sciences. Kahvejian has founded several companies such as Rubius Therapeutics, Cygnal Therapeutics, Cellarity, and Ring Therapeutics. He has also been a member of the Board of Directors and Board Observer at Codiak BioSciences.

Kahvejian's impressive resume showcases his extensive experience and expertise in the biotechnology industry. As a passionate inventor and entrepreneur, he has helped to advance novel biological mechanisms and biotechnologies, and his work has earned him a reputation as a leading figure in the field.